Mustafa Ahmed, MD
Cardiovascular Disease · Birmingham, ALNPI 1306093588
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (39.1%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 17 manufacturers reported payments, led by Medtronic at 47.2% of the total. Reporting peaked in 2024 at $67,902 and has fallen 92.2% since, to $5,285 in 2025. Among cardiovascular disease clinicians in AL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 592 payments — averaging $368.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$103K
- Abbott$60K
- Boston Scientific$23K
- Edwards Lifesciences$23K
- Philips North America LLC$8K
- Abiomed$589
- plus $1K from 11 others
Across 626 payments — averaging $3676.45 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Abbott$1.1M
- Medtronic$727K
- Boston Scientific$373K
- Philips North America LLC$64K
- Inari Medical, Inc.$47K
- Edwards Lifesciences$29K
- plus $5K from 2 others
What the payments were for
- Consulting fees$85,46039%
- Speaking & faculty fees$82,22838%
- Travel & lodging$33,22015%
- Food & beverage$17,4938%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 257 | $103,135 |
| Abbott | 159 | $59,817 |
| Boston Scientific | 45 | $23,331 |
| Edwards Lifesciences | 57 | $22,531 |
| Philips North America LLC | 20 | $7,736 |
| Abiomed | 5 | $589 |
| Angiodynamics, Inc. | 8 | $481 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 31 | $236 |
| Stryker | 1 | $169 |
| Penumbra, Inc. | 1 | $115 |
| Cardiovascular Systems Inc. | 1 | $94 |
| Chiesi USA, Inc. | 2 | $44 |
| Janssen Scientific Affairs, LLC | 1 | $42 |
| Teleflex LLC | 1 | $33 |
| Shockwave Medical, Inc | 1 | $20 |
| E.r. Squibb & Sons, L.L.C. | 1 | $15 |
| Johnson & Johnson | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- COREVALVE EVOLUT R$45,580
- CoreValve Evolut$30,524
- Mitra Clip system$21,197
- Edwards SAPIEN 3 Transcatheter Heart Valve$18,696
- WATCHMAN Access System$10,532
- MitraClip System$8,359
- VersaCross Access Solution$8,162
- IGT D Coronary$5,310
- MitraClip$4,950
- Dragonfly OCT$750
- (9520) IGT Devices Undivided$743
- (6574) Coronary Other$544
- Impella$534
- SAPIEN 3 Ultra RESILIA$279
- GENERAL - STRUCTURAL HEART$235
- (6575) Coronary Undivided$201
- VENACORE THROMBECTOMY CATHETER$169
- (0845) Combo Wire$159
- AlphaVac$138
- AngioVac$134
How this compares
$218,400 in reported general payments places this provider in the 95th percentile of 292 cardiovascular disease providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 48 | $39,327 |
| EntrestoSacubitril/Valsartan | 18 | $17,193 |
| JardianceEmpagliflozin | 19 | $16,799 |
| Repatha SureclickEvolocumab | 21 | $15,022 |
| BrilintaTicagrelor | 13 | $5,517 |
| Ranolazine ErRanolazine | 13 | $3,283 |
| ClopidogrelClopidogrel Bisulfate | 63 | $856 |
| Metoprolol Succinate | 39 | $584 |
| Atorvastatin Calcium | 42 | $427 |
| Potassium Chloride | 13 | $422 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 15 | $398 |
| Furosemide | 34 | $134 |
| Methylprednisolone | 16 | $123 |
| Losartan Potassium | 11 | $115 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Birmingham
- Vikram AroraBirmingham$271K
- Jason ThompsonBirmingham$248K
- Michael WilenskyBirmingham$241K
- Frederick GaskinBirmingham$115K
- Pankaj AroraBirmingham$83K
- Thomas CawthonBirmingham$54K
- Weihan ChenBirmingham$51K
- Farrell MendelsohnBirmingham$51K
- Charles MooreBirmingham$47K
- Christopher DegroatBirmingham$43K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.